Company profile
MESOBLAST LTD
NASDAQ:MESOBiotechnology: Biological Products (No Diagnostic Substances)
Drug pipeline (2)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| RYONCIL | approved | — | 0 | — |
| REMESTEMCEL-L | phase3 | — | 9 | no active trials |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (34)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01851070 | phase2 | completed | 2013-07-01 | 2016-05-01 | Mesoblast, Ltd. | A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor |
| NCT00225095 | phase1_2 | completed | 2005-09-01 | 2008-04-01 | Mesoblast International Sàrl | A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy |
| NCT00721045 | phase2 | completed | 2008-08-01 | 2011-06-01 | Mesoblast, Ltd. | A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure |
| NCT02336230 | phase3 | completed | 2015-06-04 | 2018-04-09 | Mesoblast, Inc. | A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD) |
| NCT07568535 | phase3 | not_yet_recruiting | 2026-08-31 | 2028-02-28 | Mesoblast, Ltd. | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease |
FDA applications (1)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| BLA 125706 | 2024-12-18 | BLA | MESOBLAST, INC. | |||||
Loading… | ||||||||